Advertisement
Document › Details
Viatris Inc.. (2/28/24). "Press Release: Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance". Pittsburgh, PA.
Organisation | Viatris GmbH [old, 2002] | |
Today | Meda Pharma GmbH (CH) | |
Group | Viatris (Group) | |
Organisation 2 | Idorsia Ltd. (SIX: IDIA) | |
Group | Idorsia (Group) | |
Product | pharmaceutical | |
Product 2 | selatogrel | |
Original document
accessed by [iito] on 2024-03-01
Record changed: 2024-03-27 |
Advertisement
More documents for Viatris (Group)
- [1] Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil....
- [2] Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top